A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

April 26, 2004

Primary Completion Date

March 1, 2006

Study Completion Date

March 1, 2006

Conditions
Infection, Human Immunodeficiency Virus IHIV Infection
Interventions
DRUG

Trizivir

DRUG

atazanavir

DRUG

Combivir

Trial Locations (45)

7017

GSK Investigational Site, East Orange

7102

GSK Investigational Site, Newark

10550

GSK Investigational Site, Mount Vernon

10595

GSK Investigational Site, Valhalla

18102

GSK Investigational Site, Allentown

19140

GSK Investigational Site, Philadelphia

19611

GSK Investigational Site, West Reading

20007

GSK Investigational Site, Washington D.C.

23666

GSK Investigational Site, Hampton

28209

GSK Investigational Site, Charlotte

29203

GSK Investigational Site, Columbia

29605

GSK Investigational Site, Greenville

30033

GSK Investigational Site, Decatur

30339

GSK Investigational Site, Atlanta

32804

GSK Investigational Site, Orlando

33136

GSK Investigational Site, Miami

33140

GSK Investigational Site, Miami Beach

33145

GSK Investigational Site, Fort Lauderdale

33306

GSK Investigational Site, Fort Lauderdale

33308

GSK Investigational Site, Fort Lauderdale

33901

GSK Investigational Site, Fort Myers

40202

GSK Investigational Site, Louisville

44304

GSK Investigational Site, Akron

44340

GSK Investigational Site, Guadalajara

60637

GSK Investigational Site, Chicago

63139

GSK Investigational Site, St Louis

64460

GSK Investigational Site, Monterrey

67214

GSK Investigational Site, Wichita

70112

GSK Investigational Site, New Orleans

70115

GSK Investigational Site, New Orleans

75208

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

77027

GSK Investigational Site, Houston

78550

GSK Investigational Site, Harlingen

78705

GSK Investigational Site, Austin

80528

GSK Investigational Site, Fort Collins

90069

GSK Investigational Site, Los Angeles

93301

GSK Investigational Site, Bakersfield

94121

GSK Investigational Site, San Francisco

94609

GSK Investigational Site, Oakland

97219

GSK Investigational Site, Portland

70127-0800

GSK Investigational Site, New Orleans

08876

GSK Investigational Site, Hillsborough

08043

GSK Investigational Site, Voorhees Township

27858-4354

GSK Investigational Site, Greenville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00082394 - A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV | Biotech Hunter | Biotech Hunter